Takashi Kojima

机构：National Cancer Center Hospital East · ORCID：0000-0002-2554-8334

发表论文 371 篇 · 总被引 12458 次 · h-index 48

代表论文

• Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer (2025 · ESMO Open · 被引 17)
• Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma – a multicenter phase 2 trial (EPOC1802) (2025 · Nature Cancer · 被引 17)
• Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 study (2025 · ESMO Open · 被引 15)
• Mathematical Modeling Predicts Optimal Immune Checkpoint Inhibitor and Radiotherapy Combinations and Timing of Administration (2024 · Cancer Immunology Research · 被引 12)
• Temporal dynamics of CLDN18.2 expression following zolbetuximab treatment in advanced gastric cancer (2025 · ESMO Gastrointestinal Oncology · 被引 10)
• First-Line Tislelizumab Plus Chemotherapy for Esophageal Squamous Cell Carcinoma with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-306 (2025 · Advances in Therapy · 被引 9)